CN106361957A - Foot patch capable of improving eyesight and reducing internal heat - Google Patents
Foot patch capable of improving eyesight and reducing internal heat Download PDFInfo
- Publication number
- CN106361957A CN106361957A CN201610953933.1A CN201610953933A CN106361957A CN 106361957 A CN106361957 A CN 106361957A CN 201610953933 A CN201610953933 A CN 201610953933A CN 106361957 A CN106361957 A CN 106361957A
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- improving eyesight
- far infrared
- foot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 42
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- 239000008589 Cortex Fraxini Substances 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 28
- 238000000137 annealing Methods 0.000 claims description 21
- 239000000919 ceramic Substances 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 241000283956 Manis Species 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000002985 plastic film Substances 0.000 claims description 3
- 229920006255 plastic film Polymers 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 18
- 206010037660 Pyrexia Diseases 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 6
- 208000030533 eye disease Diseases 0.000 abstract description 4
- 244000241872 Lycium chinense Species 0.000 abstract description 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 238000011282 treatment Methods 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 7
- 238000002653 magnetic therapy Methods 0.000 description 7
- 230000009102 absorption Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 210000000795 conjunctiva Anatomy 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 239000011324 bead Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 206010034960 Photophobia Diseases 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 206010015958 Eye pain Diseases 0.000 description 3
- 241000565359 Fraxinus chinensis Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 210000000467 autonomic pathway Anatomy 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- 241000255925 Diptera Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000008630 Sialorrhea Diseases 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000009978 visual deterioration Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000588214 Fraxinus chinensis subsp. rhynchophylla Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- QJVKUMXDEUEQLH-UHFFFAOYSA-N [B].[Fe].[Nd] Chemical compound [B].[Fe].[Nd] QJVKUMXDEUEQLH-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000013039 cover film Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- -1 leads to liver Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Pathology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a traditional Chinese medicine patch, in particular to a foot patch capable of improving eyesight and reducing internal heat. The foot patch contains patch preparing auxiliary materials. The medicinal effective ingredients of the foot patch include, by weight, 18-22 parts of rhizoma coptidis, 8-12 parts of lycium chinense, 2.5-3.5 parts of pangolin scales, 18-22 parts of radix scutellariae, 18-22 parts of Chinese yam, 18-22 parts of fructus corni, 25-35 parts of chrysanthemum flowers, 8-12 parts of rhizoma anemarrhenae, 25-35 parts of honeysuckle flowers, 8-12 parts of semen cassiae, 8-12 parts of fructus gardeniae, 8-12 parts of cortex phellodendri, 8-12 parts of radix rehmanniae praeparata, 8-12 parts of cortex fraxini and 8-12 parts of cortex lycii radicis, all of which are prepared into a medicine cake. The foot patch has the functions of alleviating fever, removal internal heat, tonifying the kidneys and lowering internal heat, and has a significant effect in adjuvant treatment of eye diseases and excessive internal heat.
Description
Technical field
The present invention relates to a kind of Chinese medicine patch, i.e. improving eyesight annealing foot patch.
Background technology
In the prior art, be directed to removing toxic substances, fire of dispelling, improving eyesight, kidney tonifying class product from ancient times to the present many, have oral, injection,
The multiclass such as cream, scattered external.Have pure Chinese medicine, have compound recipe, technique has traditional, has modern technologies, excellent, inferior position respectively has not
With.But most products are it is impossible to reach not only safely, effectively but also the therapeutic that has no side effect, more do not reach convenient, usability.Mouthful
Take medicine, all can be difficult to entrance, or even have untoward reaction, more lack convenient effective therapeutic.The shortcoming of medicine for external use, is not
Remote medication can be reached it is impossible to targeting accurately corresponds to accurate purpose and the effect of the treatment such as eye, nose, pharynx, ear, the heart, liver, kidney.
Some medicine for external use, are applied directly to organizer official rank position, cause at a specified future date and recent drug induccd to damage now, such as medicament for the eyes, eye
Patch, rhinitis spray etc., these are all inferior position in treatment and use for these products and deficiency, do not reach comprehensive optimal treatment
Property.
Content of the invention
The purpose of the present invention is for above-mentioned not enough and provide a kind of improving eyesight annealing foot to paste, solve treatment disease of eye and
Intimately the problem of high Sheng aspect is not it is achieved that " controlling " disease simultaneously, " causes " purpose of sick and convenient use.
The technical solution of the present invention is: improving eyesight annealing foot pastes, including system patch adjuvant it is characterised in that it is medicinal effectively
Composition makes medicine cake: Rhizoma Coptidis 18-22 part, Fructus Lycii 8-12 part, Squama Manis 2.5-3.5 part, Radix Scutellariae by the raw material of following parts by weight
18-22 part, Rhizoma Dioscoreae 18-22 part, Fructus Corni 18-22 part, Flos Chrysanthemi 25-35 part, Rhizoma Anemarrhenae 8-12 part, Flos Lonicerae 25-35 part,
Semen Cassiae 8-12 part, Fructus Gardeniae 8-12 part, Cortex Phellodendri 8-12 part, Radix Rehmanniae Preparata 8-12 part, Cortex Fraxini 8-12 part, Cortex Lycii 8-12
Part；By medicated powder total amount 15-25 % about add far infrared ceramic powder.
Preferably: improving eyesight annealing foot patch is it is characterised in that be made up of the raw material of following weight grams: 20 grams of Rhizoma Coptidis, Fructus Lycii 10
Gram, 3 grams of Squama Manis, 20 grams of Radix Scutellariae, 20 grams of Rhizoma Dioscoreae, 20 grams of Fructus Corni, 30 grams of Flos Chrysanthemi, 10 grams of the Rhizoma Anemarrhenae, 30 grams of Flos Lonicerae, Semen Cassiae 10
Gram, 10 grams of Fructus Gardeniae, 10 grams of Cortex Phellodendri, 10 grams of Radix Rehmanniae Preparata, 10 grams of Cortex Fraxini, 10 grams of Cortex Lycii；15-25% by medicated powder total amount
Add far infrared ceramic powder.
In such scheme, medicine cake is placed with magnetic.Far infrared wavelength 7um-14um, emissivity is not less than 70%, magnetic
The magnetic field intensity that body produces is not less than 2.5gs.
1) 2.5gs magnetostatic to microcirculatory improvement result, adjust nervus vasculairs function；By the impression of human skin tissue
Device is upset, and causes to reflexive vasodilation, produces slight fever effect, and change is that magnetic field has antiinflammatory, detumescence, pain relieving work
With.
2) effect to trace element and mineral absorption for the 2.5gs magnetic, contains substantial amounts of potassium, sodium, calcium in blood, ferrum etc. is charged
Ion, under the influence of a magnetic field, makes the translational speed of these ions accelerate, so that the translational speed of erythrocyte is also accelerated, and reduces red
The aggregation of cell, promotes body to trace element and mineral absorption.
3) improvement result to cellular metabolic activity for the 2.5gs magnetic, in human tissue cell there is trace magnetic in charge movement
?.
4) effect to enhance immunity for the 2.5gs magnetic, magnetic therapy can improve immune technical ability, excites huge in vivo biting carefully
The phagocytic activity of born of the same parents.Many people's reflections using magnetic therapy product, not only seldom catch a cold, and other infect disease and also substantially subtract
Few.The result of this exactly magnetic therapy enhance immunity.
According to surveying and determination: the far infrared wavelength of human-body emitting is in 9.6 microns, for this reason, compounding far infrared powder is produced
The wavelength of raw far infrared is in 7um-14um preferred 9-11 micron, and human body surface peak value just matches, and forms optimal absorption
And the interior energy of human body can be converted into, there is good absorption resonance.
Rhizoma Coptidis, Coptiss Ranunculaceae, Coptiss herbaceos perennial, there is the effect of heat clearing and damp drying, eliminating fire and detoxication.
Fructus Lycii, is plant of Solanaceae, nourishing the liver and kidney, replenishing vital essence to improve eyesight.Squama Manis, are the scute of Manidae animal Manitiss, and detumescence is burst
Carbuncle, it is active to search wind, stimulating milk secretion of stimulating the menstrual flow.
Radix Scutellariae, is lamiaceae labiatae scutellaria herbaceos perennial, and the root of Radix Scutellariae is used as medicine, bitter in the mouth, cold in nature, have heat clearing and damp drying,
Eliminating fire and detoxication, hemostasis, antiabortive the effects such as.
Rhizoma Dioscoreae, medicinal source is Dioscoreaceae plant Rhizoma Dioscoreae dry rhizome.Rhizoma Dioscoreae have nourishing strong, aid digestion, hold back sweating due to debility,
The effect of antidiarrheal,
Fructus Corni, is the drying and ripening sarcocarp of dicotyledon medicine Cornaceae plant Fructus Corni.Invigorating the liver and kidney, arresting seminal emission gas, Gu empty
De-.
The Rhizoma Anemarrhenae, Liliaceae, clearing away heat-fire, nourshing Yin and drynsessmoistening prescription.
Flos Lonicerae, Caprifoliaceae, heat and toxic materials clearing away medicine.
Semen Cassiae, is the dry mature seed of leguminous plant Semen Cassiae or little Cassia tora, the work(of improving eyesight is had with it and name it.Have
Loosening bowel to relieve constipation, lipid-loweringing improving eyesight effect.
Fructus Gardeniae, is the fruit of Maguireothamnus speciosus Fructus Gardeniae.There is the effect such as hepatoprotective, function of gallbladder promoting, blood pressure lowering, calmness, hemostasis, detumescence.
Cortex Phellodendri, is the dry bark of rutaceae wampee.There are heat clearing and damp drying, purging intense heat, except steaming, effect of detoxification sore treatment.
Radix Rehmanniae Preparata, Scrophulariaceae, Radix Rehmanniae platymiscium, close by the long pubescence of canescence many cells and glandular hair.There are heart tonifying, diuresis, fall
Blood glucose and rising peripheral leukocytes, strengthen the effect such as immunologic function.
Cortex Fraxini, be Oleaceae plants fraxinus rhynchophylla Hance, Chinese ash, sharp leaf Chinese ash or place post Chinese ash be dried branch skin or
Dried bark.Heat clearing and damp drying, astringent therapy dysentery relieving, leukorrhagia stopping, improving eyesight.
Cortex Lycii, is Solanaceae, Lycium, is the root bark of Fructus Lycii lycium chinense mill..Removing heat from blood removes and steams,
Lung heat clearing pathogenic fire reducing.For deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat, spitting of blood, epistaxis.Heat Diabetes.
Far infrared ceramic powder is a kind of white powder, is mixed by many kinds of substance.Far infrared ceramic powder is radiating
Going out more far infrareies (infrared emittance is higher) than normal object is main feature functionality.Far infrared ceramic powder commercially produces
Product, as on sale in Hebei Jing Hang mineral products company limited.
The preparation method of improving eyesight annealing foot patch is it is characterised in that step is as follows: by the medicated powder preparing and far-infrared ceramic
Powder fully mixes with putting in agitator tank, then substrate is poured into fully stirs companion in it, and the medicine puree stirring evenly is put in container, then will
Medicine puree is positioned on clod molding press, and standard makes medicine cake by weight, then medicine cake is put on carrier sticker, by magnetic (magnetic
Treat pearl) it is put in middle part on medicine cake, cover plastic film coated, load plastic packaging bag, be put into disinfection room and carry out oxirane disinfection,
Product storage is standby.
This product structure and composition: using Chinese medicine and far infrared ceramic powder, magnetic material, medical non-woven compress, medical
Pressure sensitive adhesive, substrate and carrier material composition.Far infrared wavelength 7um-14um(micron), emissivity is not less than 70%, and magnetic material produces
Raw magnetic field intensity is not less than 2.5gs.Through 100,000 grades of Workshop Production that sterilize.This product energy benefiting kidney-YIN is not enough, increases kidney water
Above defeated to cloudy liquid, by enlivening gas in kidney channel, vital base and primordial QI consolidating, radiating is angry, makes kidney channel sufficient, Yongquan acupoint is the well cave of kidney channel,
Well cave is to belong to wood, leads to liver, water again raw wood it is possible to excavation energy tonifying liver from here.When eyes are uncomfortable it is simply that
Liver is being cried for help to kidney it is desirable to some kidney yins of kidney channel (water) to reduce the fire of moxibustion of liver it is impossible to declare the liver-fire sending out, heart-fire etc.
Excess-fire interior-heat, by the magnetic therapy reagentia with reference to far infrared, magnetic bead, and the superconductivity of product, reach kidney tonifying, heat clearing away,
Removing toxic substances, annealing are ignited descending.
Processing step: same to the Chinese herbal medicine preparing nano powder and far infrared ceramic powder putting in agitator tank is fully mixed, then
Substrate is poured into and in it, fully stirs companion, the medicine puree stirring evenly is put in container, then medicine puree is positioned on clod molding press, press
Every 2 grams of standard makes medicine cake, then medicine cake is put on carrier sticker, magnetic therapy pearl is put in the middle part on medicine cake, covers
Plastic film coated, load plastic packaging bag, be put into disinfection room and carry out oxirane disinfection, product storage is standby.
Medical adhesive-bonded fabric breathability strong medical pressure-sensitive adhesive antiallergic, the emitting far-infrared expansion of nano-scale far infrared ceramic powder
Open blood capillary, blood circulation promoting, bring back to life ferment, strengthening blood and cell tissue metabolism, strengthen liver function.
The Main Physical Characteristics of far infrared are as follows:
1st, emissivity: because far infrared is belonging to the electromagnetic wave of light range, it does not need any matchmaker as light
It is situated between and just can directly conduct, here it is far emissivity.
2nd, permeability (penetration): although far infrared is belonging to the electromagnetic wave of light, with other visible rays on penetration
Different.Far infrared has the penetration power of uniqueness, and its energy can be applied to subcutaneous tissue certain depth, then passes through blood circulation,
Energy is reached in deep tissues and organ.Here it is the permeability of far infrared.
3rd, absorption resonance: according to Kirchhoff's law of radiation: any good radiant body, necessarily good absorber.?
Under same temperature, radiant body ability is bigger, and its absorbing power is stronger, and both are proportional, all objects containing far infrared,
Both can radiation infrared it is also possible to absorb far infrared, radiation with absorb equity.And human body is all the time also all in transmitting
Far infrared,
The effect to human body for the far infrared: using far infrared reaction, so that subcutaneous deep skin temperature is increased, expand blood capillary,
Blood circulation promoting, brings back to life ferment, strengthening blood and cell tissue metabolism, recovers youth to cell and is very helpful and can change
Kind anemia.
Adjust blood pressure: and arteriosclerosis are usually nervous system hormonal system, the tiny arterial contraction such as kidney and narrow made
Become.Far infrared expands blood capillary, and blood circulation promoting can make reduction, can improve hypostension again.
Improve arthralgia: far infrared penetration, up to muscle arthrosis depths, makes warm in body, relaxs one's muscles, drive micro-
The oxygen of vasoganglion and nutrient exchange, and exclude the aging wastes such as the internal fatigue substances of accumulation and lactic acid to swollen in eliminating, and delay
Remarkable with the effect ached.
Adjust autonomic nerve: autonomic nerve mainly adjusts viscera function, and people is in anxiety state for a long time, and autonomic nervous system is held
Continuous anxiety, can lead to immunity to reduce, and headache is dizzy, weak, cold limbs of having a sleepless night.Far infrared scalable autonomic nerve is protected
Hold in optimum state, above symptom all can be improved or dispel.
Improve looks: far infrared irradiates human body empathizes absorptions, can cause tired and aging material, such as lactic acid is free
Unnecessary subcutaneous fat of fatty acid cholesterol etc., the reactivity of nationality follicular orifice and subcutaneous fat, without kidney, directly from skin generation
Thank.Accordingly, it is capable to make skin smooth tender.
Reduce fat: the physiotheraping effect of far infrared can make internal heat energy high, cell activation therefore promotes fatty tissue metabolism,
Combustion decomposition, superabundant fats are consumed, and then effectively.
Improve blood circulation: the comprehensive and permeability that far infrared irradiates, for spreading all over micro- the following being difficult number meter inside and outside whole body
Ring tissue system, be uniquely can treatment completely physical therapy mode.After microcirculation is smooth, cardiac systolic pressure mitigate, oxygen and
Nutrient supply is sufficient, and the light body of natural body is good for.
Strengthening liver function: liver is chemical plant maximum in vivo, is the depurator of blood.The body that far infrared irradiation causes
Interior-heat deep layer effect, energy activating cell, high tissue regeneration ability, promote cell growth, strengthen liver function, high liver detoxification row
Toxic action, makes internal organs environment maintain a good state, and can say it is optimal diseases prevention strategy.
Function: heat clearing away, annealing, kidney tonifying, ignite descending.Treatment disease of eye and intimately high Sheng aspect are had effective.
Usage and dosage: external.After clean skin, paster is thrown off transparent protective film, be affixed on Yongquan points on double feet cave.Daily 1-2 time, often
Secondary 3-4 hour.Also front use can be slept evening, morning next day takes off.Right
The course for the treatment of: usage cycles 7 days about.User, according to symptom, can increase and decrease each use time, natural law and number of times as one sees fit.
The invention has the advantage that 1, adopt Song Shi ancient prescription, carry modern science and technology, add that the compositions such as substrate constitute entirely
New green product.This pastes the transdermal treatments with the traditional Chinese medical science enough, in conjunction with the magnetotherapy effect of magnetic bead, medicine is passed through vola Yongquan acupoint
The skin of position imports in vivo, plays the dual function of drug effect, acupoint stimulation, reaches purpose of curing the disease.It is truly realized headache and do not cure head,
Ophthalmic does not cure eye, far-end list point-application, and targeting precisely treats the unique method of zang-fu diseases.2nd, this product energy benefiting kidney-YIN is not
Foot, increase kidney waterborne defeated by enlivening gas in kidney channel, vital base and primordial QI consolidating, radiating is angry to cloudy liquid, make kidney channel sufficient it is impossible to a surname
The excess-fire interior-heat such as the liver-fire that sends out, heart-fire, by the magnetic therapy reagentia with reference to far infrared, magnetic bead, and product is super
The property led, reach kidney tonifying, heat clearing away, removing toxic substances, anneal, ignite descending.3rd, realize green auxiliary treatment.Come from this product raw material
It is that three's effect is worked in coordination with mutually, and the characteristic of material itself is all with Chinese medicine, far infrared ceramic powder and magnetic bead and substrate composition
The material that body is had no adverse effects；It is, by far-end vola Yongquan acupoint transdermal treatments, its composition is imported body on using therapy
Interior, it is not directly contacted with eyes and other organs itself, will not bring to these positions and not accommodate inconvenience moreover it is possible to the essence that plays targeting
Quasi- therapeutic purposes.
Below in conjunction with embodiment, embodiments of the present invention are described in further detail.
Specific embodiment
Embodiment
Improving eyesight annealing foot paste, include system paste adjuvant, be made up of the raw material of following weight grams: 20 grams of Rhizoma Coptidis, 10 grams of Fructus Lycii,
3 grams of Squama Manis, 20 grams of Radix Scutellariae, 20 grams of Rhizoma Dioscoreae, 20 grams of Fructus Corni, 30 grams of Flos Chrysanthemi, 10 grams of the Rhizoma Anemarrhenae, 30 grams of Flos Lonicerae, 10 grams of Semen Cassiae,
10 grams of Fructus Gardeniae, 10 grams of Cortex Phellodendri, 10 grams of Radix Rehmanniae Preparata, 10 grams of Cortex Fraxini, 10 grams of Cortex Lycii；Chinese medicine powder makes granularity 180 mesh, and far infrared is made pottery
Porcelain powder is 1: 4 with the ratio of weight and number of Chinese medicine powder component.Put same to the medicated powder preparing and far infrared ceramic powder in agitator tank
Fully mix, then (plaster substrate as conventional in Mel, azone, paraffin, glycerol, vaseline etc., such as by medicated powder and far infrared by substrate
The 30-50% of ceramics total amount adds substrate) pour into and in it, fully stir companion, the medicine puree stirring evenly is put in container, then by medicine
Mud is positioned on clod molding press, makes medicine cake by every 2 grams of standard, then medicine cake is put on carrier sticker, by magnetic therapy pearl (such as
Diameter 2mm about, material neodymium iron boron, one or more, 1.6mm in this example) be put in middle part on medicine cake, cover plastics and cover
Film, loads plastic packaging bag, is put into disinfection room and carries out oxirane disinfection, product storage is standby.
After testing, improving eyesight annealing foot pastes far infrared wavelength 7um-14um, and emissivity is not less than 70%, the magnetic that magnetic produces
Field intensity is not less than 2.5gs.For ensureing the ageing of product, just make parameter when purchasing raw material, and press parameter and standard
Allow supplier produce far infrared ceramic powder and magnetic bead, the normal intensity of formulation can be reached.
Experimental example
Case 1: Mrs Li, 45 years old age readme eyes eye is done, eye is puckery, ocular pain, conjunctival congestion, photophobia is shed tears, eye divides
Many two days of secretion.History of present illness: this trouble is stayed up late because of two days causes after getting angry, and above-mentioned symptom immediately, personal chlormycetin eye ointment
Water droplet eye has no positive effect, and exacerbation of symptoms tends to, and controls to hospital for seeing a doctor, and in the course of disease, diet sleep is fine.Physical examination:
General state can, the circle light reflection of the Datong District such as pupil of both eyes exists, photophobia, and palpebral conjunctiva hyperemia (+++), edema, secretions amount are many, yellow
Color, remaining and no abnormality seen.Clinical diagnosises are that conjunctiva of both eyes is scorching.Dispose: improving eyesight annealing foot patch 28 patches are twice a day 4 little every time
When or this patch be affixed on Yongquan points on double feet cave daily evening before sleep, morning next day takes off.Follow-up: paste morning next day self-induction using improving eyesight annealing foot
Eyes are done, eye is puckery, ocular pain, conjunctival congestion, discharge of eye phenomenon substantially mitigate.When three days photophobia shed tears, ocular pain, knot
If film is congested, discharge of eye phenomenon has presence, after 7 days, malaise symptoms disappear, disease recovery from illness.)
Case 2: Mr. Yang, at 50 years old age, readme eyes eye is done, eye is puckery, eyestrain, visual deterioration, have winged mosquito existing at the moment
As, with irritable more than half a year.History of present illness: this trouble, because of long campaigns office work, contacts electronic product frequently, nearly half a year
Substantially feel that above-mentioned exacerbation of symptoms, personal resisting fatigue eye dropping of eye drops and oral cow-bezoar bolus for clearing away heat of the upper part of the body have no and are obviously improved, for seeing a doctor
Control to hospital, in the course of disease, diet sleep is fine.Physical examination: general state can, the Datong District such as pupil of both eyes circle light reflection exist,
Photophobia, palpebral conjunctiva congested (+), no secretions, no cataract, remaining and no abnormality seen.Clinical diagnosises are eyes xerophthalmia eyes
Feature goes down.Dispose: twice a day 4 hours or this patch are affixed on biped to improving eyesight annealing foot patch 40 patch daily evening before sleep every time
Yongquan acupoint, morning next day takes off.Follow-up: after being pasted two using improving eyesight annealing foot, self-induction eyes are done, eye is puckery, eyestrain, phenomenon are bright
Aobvious mitigation has the lubricious sense of eyes.When five days, eyes eye is done, eye is puckery, eyestrain, phenomenon do not have substantially, visual deterioration, has at the moment
Winged mosquito phenomenon, companion's irritable slightly exist, disease recovery from illness after 10 days.)
Case 3: Mrs Wang, 9 months female's ages of sex.Head of a family's Dai Shu infant sialorrhea, object for appreciation tongue, discharge of eye are many, handss, arch of the foot
And feverish sensation in the head occurs together and burns one day for five days.History of present illness: this infant above-mentioned symptom because of inducement no obvious before five days, from the head of a family to mouth
Take Pu bring down a fever piece and have no positive effect, fever symptoms increase to tend to, and control for seeing a doctor to hospital, and in the course of disease, milk amount reduces,
Sleep is felt unwell, yellowish or reddish urine, is hard and dry.Physical examination: body temperature: 38.9 DEG C, 110 beats/min of pulse, general state can, eyes
Palpebral conjunctiva hyperemia (++), the many yellow of secretions amount, pharyngeal tonsil hyperemia (++), edema (+), nasal decongestion (++).Yellow fur
Greasy, no abnormality seen more than the heart, lung, abdomen.Clinical diagnosises are that upper respiratory tract infection conjunctiva of both eyes is scorching.Dispose: improving eyesight annealing foot patch 28
Patch twice a day every time 3 hours, is affixed on Yongquan points on double feet cave.Continue oral Pu bring down a fever piece.Follow-up: this suffers from head of a family Dai Shu makes
Have no temperature after being pasted four hours with improving eyesight annealing foot, temperature recovery is normal.3rd day infant sialorrhea, play tongue, discharge of eye many,
Handss, arch of the foot and feverish sensation in the head phenomenon substantially mitigate.During the 5th Tian Lai institute further consultation sky, eyes palpebral conjunctiva is no congested, no secretions, swallows almond
Body congested (+-), edema (0), nasal decongestion (+-) after 7 days all suitable symptoms disappear, disease recovery from illness.)
Clinic uses to successively more than 300 disease of eye patient, obvious effective rate 93%, effective percentage 7%, total effective rate 100%.
It is described above, simply the specific embodiment of the present invention, the various illustrations not flesh and blood structure to the present invention
Become to limit.
Claims (5)
1. improving eyesight annealing foot paste, include system paste adjuvant it is characterised in that its effective medicinal components by following parts by weight raw material
Make medicine cake: Rhizoma Coptidis 18-22 part, Fructus Lycii 8-12 part, Squama Manis 2.5-3.5 part, Radix Scutellariae 18-22 part, Rhizoma Dioscoreae 18-22 part, mountain
Fructus Corni 18-22 part, Flos Chrysanthemi 25-35 part, Rhizoma Anemarrhenae 8-12 part, Flos Lonicerae 25-35 part, Semen Cassiae 8-12 part, Fructus Gardeniae 8-12
Part, Cortex Phellodendri 8-12 part, Radix Rehmanniae Preparata 8-12 part, Cortex Fraxini 8-12 part, Cortex Lycii 8-12 part；Add by the 15-25% of medicated powder total amount
Enter far infrared ceramic powder.
2. according to the improving eyesight annealing foot patch described in claim 1 it is characterised in that being made up of the raw material of following weight grams: Rhizoma Coptidis
20 grams, 10 grams of Fructus Lycii, 3 grams of Squama Manis, 20 grams of Radix Scutellariae, 20 grams of Rhizoma Dioscoreae, 20 grams of Fructus Corni, 30 grams of Flos Chrysanthemi, 10 grams of the Rhizoma Anemarrhenae, Flos Lonicerae 30
Gram, 10 grams of Semen Cassiae, 10 grams of Fructus Gardeniae, 10 grams of Cortex Phellodendri, 10 grams of Radix Rehmanniae Preparata, 10 grams of Cortex Fraxini, 10 grams of Cortex Lycii；By medicated powder total amount
20% addition far infrared ceramic powder.
3. according to the improving eyesight annealing foot patch described in claim 1 or 2 it is characterised in that being placed with magnetic on medicine cake.
4., according to the improving eyesight annealing foot patch described in claim 3 it is characterised in that far infrared wavelength 7um-14um, emissivity is not low
In 70%, the magnetic field intensity that magnetic produces is not less than 2.5gs.
5. a kind of preparation method of improving eyesight annealing foot patch as claimed in claim 3 is it is characterised in that step is as follows: will prepare
Medicated powder and far infrared ceramic powder fully mix with putting in agitator tank, then substrate poured into fully stir companion in it, by stir evenly
Medicine puree is put in container, then medicine puree is positioned on clod molding press, and standard makes medicine cake by weight, then medicine cake is put into carrier
On sticker, magnetic is put in the middle part on medicine cake, covers plastic film coated, load plastic packaging bag, be put into disinfection room and carry out ring
Oxidative ethane is sterilized, and product storage is standby.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610953933.1A CN106361957A (en) | 2016-11-03 | 2016-11-03 | Foot patch capable of improving eyesight and reducing internal heat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610953933.1A CN106361957A (en) | 2016-11-03 | 2016-11-03 | Foot patch capable of improving eyesight and reducing internal heat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106361957A true CN106361957A (en) | 2017-02-01 |
Family
ID=57893638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610953933.1A Pending CN106361957A (en) | 2016-11-03 | 2016-11-03 | Foot patch capable of improving eyesight and reducing internal heat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106361957A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN204133876U (en) * | 2014-09-10 | 2015-02-04 | 天津法莫西医药科技有限公司 | A kind of improvement foot pastes |
| CN105535293A (en) * | 2016-01-12 | 2016-05-04 | 郭玉娥 | Health care foot patch and external application medicine powder thereof |
-
2016
- 2016-11-03 CN CN201610953933.1A patent/CN106361957A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN204133876U (en) * | 2014-09-10 | 2015-02-04 | 天津法莫西医药科技有限公司 | A kind of improvement foot pastes |
| CN105535293A (en) * | 2016-01-12 | 2016-05-04 | 郭玉娥 | Health care foot patch and external application medicine powder thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104473759B (en) | The tarsal glands heating of a kind of xerophthalmia and device for fumigation | |
| CN103520578A (en) | Traditional Chinese medicine composition for treating oral ulcer and preparation method thereof | |
| CN103083514A (en) | Anti-aging traditional Chinese medicine composition | |
| CN102988273A (en) | Whitening and freckle-removing Chinese medicinal mask | |
| CN103083412A (en) | Traditional Chinese medicine for treating premature graying | |
| CN102846955A (en) | Chinese herbal medicine heightening insole | |
| CN102908474B (en) | Medicinal liquor for treating neurosis | |
| CN107789521A (en) | It is a kind of to alleviate kopiopia, the compound traditional Chinese medicine composite eye sticker for the treatment of myopia | |
| CN104208423A (en) | Traditional Chinese medicine for treating nyctalopia | |
| CN103007214B (en) | Chinese medicinal composition for treating palpitation | |
| CN102389469B (en) | Foot bathing health care medicament | |
| CN108272986A (en) | A kind of draft is bathed powder | |
| CN106361957A (en) | Foot patch capable of improving eyesight and reducing internal heat | |
| CN102526541B (en) | Composition for effectively conditioning female climacteric syndrome | |
| CN101985018A (en) | Chinese herbal medicine for treating enuresis of children | |
| CN103479709A (en) | Traditional Chinese medicine used for treating neonatal jaundice | |
| CN104687137A (en) | Formula and production method of pilose antler brain-strengthening nerves-calming soup material | |
| CN103721072B (en) | Improve the medicine pill of sexual impotence, premature ejaculation | |
| CN103463522A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN107349395A (en) | For treating neurasthenic Chinese medicine preparation | |
| CN102357157B (en) | Traditional Chinese medicine composition for treating skin acne with mite infection | |
| CN102772620B (en) | Medicine for inhibiting recurrence of cancer after surgery | |
| CN106668552A (en) | Medicine bag for treating deficiency of kidney | |
| CN106310082A (en) | Kidney-tonifying traditional Chinese medicine composition and preparation method thereof | |
| CN101843810A (en) | Medicinal liquor for treating bi syndromes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |